ADIM
CHE icon

Alpha DNA Investment Management’s Chemed CHE Stock Holding History

Alpha DNA Investment Management’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-113
Closed -$51K – 193
2021
Q1 		$51K Buy
113
+14
+14% +$6.86K 0.06% 168
2020
Q4 		$52K Buy
+99
New +$48.6K 0.06% 177

Other funds holding CHE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Alpha DNA Investment Management's CHE Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Chemed (CHE) in Q2 2021, closing a stake of 113 shares — an estimated $51K sold.

Alpha DNA Investment Management first reported a position in CHE in Q4 2020 and held it in 2 quarters. The position peaked at $52K in Q4 2020. 425 funds tracked by Wall St. Rank hold CHE as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Chemed position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 113 Chemed shares in Q2 2021, an estimated $51K.
  • Alpha DNA Investment Management first reported a position in Chemed in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's Chemed position peaked at $52K in Q4 2020.
  • 425 funds tracked by Wall St. Rank held Chemed as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.